SCHEMBL3085221

SCHEMBL3085221

O=C(O)[C@H](Cc1c[nH]cn1)N1C(=O)CCC1=O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.52
PKM P14618 2/20 0.52
HIF1A Q16665 1/20 0.36
PPM1B O75688 2/20 0.35
GAA P10253 1/20 0.33
DNMT1 P26358 3/20 0.33
KMT2A Q03164 2/20 0.32
CYP2C19 P33261 1/20 0.32
DNMT3B Q9UBC3 1/20 0.32
HDAC3 O15379 1/20 0.31
HDAC4 P56524 1/20 0.31
HDAC1 Q13547 1/20 0.31
HDAC7 Q8WUI4 1/20 0.31
HDAC2 Q92769 1/20 0.31
HDAC10 Q969S8 1/20 0.31
HDAC11 Q96DB2 1/20 0.31
HDAC8 Q9BY41 1/20 0.31
HDAC6 Q9UBN7 1/20 0.31
HDAC9 Q9UKV0 1/20 0.31
HDAC5 Q9UQL6 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17525717 0.96 ALDH1A1 (0.48) ALDH1A1PKMHIF1APPM1BGAA
SCHEMBL2443510 0.96 ALDH1A1 (0.48) ALDH1A1PKMHIF1APPM1BGAA
SCHEMBL3072878 0.86 ALDH1A1 (0.38) ALDH1A1PKM
SCHEMBL3083996 0.86 ALDH1A1 (0.38) ALDH1A1PKM
SCHEMBL6996873 0.85 ALDH1A1 (0.37) ALDH1A1PKM
SCHEMBL17525693 0.84 ALDH1A1 (0.38) ALDH1A1PKMHIF1APPM1B
SCHEMBL3085673 0.84 ALDH1A1 (0.36) ALDH1A1PKMKMT2ASLC1A2
SCHEMBL3081013 0.84 ALDH1A1 (0.36) ALDH1A1PKM
SCHEMBL3072474 0.84 ALDH1A1 (0.36) ALDH1A1PKM
SCHEMBL4623529 0.83 ALDH1A1 (0.35) ALDH1A1PKMHIF1AKMT2ATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1905763-B1 N-ACYLIC AMINOACID DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, PHARMACOLOGICAL COMPOSITION AND THE USE IN THE FORM OF ANTI-ALLERGIC, ANTI-INFLAMMATORY AND HYPOLIPIDEMIC AGENTS NEBOLSIN VLADIMIR EVGENIEVICH (RU) 2019-05-08 EP claimed
US-8940780-B2 N-acylic aminoacid derivatives, method for the production thereof, pharmacological composition and the use in the form anti-allergic, anti-inflammatory and hypolipidemic agents OTKRYTOE AKTSIONERNOE OBSCHESTVO OTECHESTVENNYE LEKARSTVA (RU) 2015-01-27 US claimed
EP-1905763-B1 N-ACYLIC AMINOACID DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, PHARMACOLOGICAL COMPOSITION AND THE USE IN THE FORM OF ANTI-ALLERGIC, ANTI-INFLAMMATORY AND HYPOLIPIDEMIC AGENTS NEBOLSIN VLADIMIR EVGENIEVICH (RU) 2019-05-08 EP disclosed
US-8940780-B2 N-acylic aminoacid derivatives, method for the production thereof, pharmacological composition and the use in the form anti-allergic, anti-inflammatory and hypolipidemic agents OTKRYTOE AKTSIONERNOE OBSCHESTVO OTECHESTVENNYE LEKARSTVA (RU) 2015-01-27 US disclosed
US-8318950-B2 N-acyl amino acid derivatives, a method for the preparation thereof, a pharmaceutical composition and use thereof as anti-allergic, anti-inflammatory and hypolipidemic agents Otkrytoe Aktsionernoe Obschestvo-Otechestvennye Lekarstva (RU) 2012-11-27 US disclosed
US-20100267962-A1 N-ACYLIC AMINOACID DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, PHARMACOLOGICAL COMPOSITION AND THE USE IN THE FORM ANTI-ALLERGIC, ANTI-INFLAMMATORY AND HYPOLIPIDEMIC AGENTS Nebolsin, Vladimir Evgenievich (RU) 2010-10-21 US disclosed
US-20080319040-A1 N-Acylic Aminoacid Derivatives, Method For The Production Thereof, Pharmacological Composition And The Use In The Form Anti-Allergic, Anti-Inflammatory And Hypolipidemic Agents OTKRYTOE AKTSIONERNOE OBSCHESTVO "OTECHESTVENNYE LEKARSTVA (RU) 2008-12-25 US disclosed
EP-1905763-A1 N-ACYLIC AMINOACID DERIVATIVES. METHOD FOR THE PRODUCTION THEREOF, PHARMACOLOGICAL COMPOSITION AND THE USE IN THE FORM OF ANTI-ALLERGIC, ANTI-INFLAMMATORY AND HYPOLIPIDEMIC AGENTS Nebolsin, Vladimir Evgenievich (RU) 2008-04-02 EP disclosed
EP-0666753-B9 Use of peptides FOR THE TREATMENT OF THE COMPLICATIONS AND PATHOLOGY OF DIABETES PEPTECH LTD (AU) 2002-06-12 EP disclosed
EP-0666753-B1 Use of peptides FOR THE TREATMENT OF THE COMPLICATIONS AND PATHOLOGY OF DIABETES PEPTECH LIMITED (AU) 2000-11-22 EP disclosed
US-5561110-A ADMINISTERING OLIGOPEPTIDE PEPTIDE TECHNOLOGY LIMITED (AU) 1996-10-01 US disclosed
EP-0666753-A1 METHOD FOR THE TREATMENT OF THE COMPLICATIONS AND PATHOLOGY OF DIABETES PEPTIDE TECHNOLOGY LTD (AU) 1995-08-16 EP disclosed
EP-0666753-A4 METHOD FOR THE TREATMENT OF THE COMPLICATIONS AND PATHOLOGY OF DIABETES. PEPTIDE TECHNOLOGY LTD (AU) 1995-01-26 EP disclosed
WO-1993004690-A1 METHOD FOR THE TREATMENT OF THE COMPLICATIONS AND PATHOLOGY OF DIABETES PEPTIDE TECHNOLOGY LIMITED (AU) 1993-03-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100267962-A1 N-ACYLIC AMINOACID DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, PHARMACOLOGICAL COMPOSITION AND THE USE IN THE FORM ANTI-ALLERGIC, ANTI-INFLAMMATORY AND HYPOLIPIDEMIC AGENTS HRH4, HRH2, AADAT ALDH1A1 4093/4885PKM 4226/4885HIF1A 1206/4885
US-20080319040-A1 N-Acylic Aminoacid Derivatives, Method For The Production Thereof, Pharmacological Composition And The Use In The Form Anti-Allergic, Anti-Inflammatory And Hypolipidemic Agents HRH4, HRH2, AADAT ALDH1A1 4093/4885PKM 4226/4885HIF1A 1206/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.